Figure 3
From: Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Correlation of IGFL2 with immune cells. (A) Correlation of IGFL2 expression with 6 immune cell types in the TIMER algorithm. (B) Correlation of IGFL2 with 22 immune cell subtypes in the CIBERSORT algorithm.
